Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Merck Sharp & Dohme LLC
Age
50–75
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Patient does not have hypertension or has Stage I or II hypertension and is taking \< 3 anti-hypertension medications
Patient is willing to discontinue all anti-hypertensive medications during study
Patient is willing to refrain from drinking alcohol for 24 hours prior to each study visit and is willing to limit intake at other times during the study to 2 drinks per day
Patient agrees to avoid caffeine for 24 hours prior to each study visit. At other times during study, daily caffeine intake should not exceed 4 cups of coffee (or equivalent)
Patient will avoid strenuous physical activity during study
Patient is a nonsmoker or has not smoked for the last 3 months
You may not be if
Patient has metal implants in the leg or artificial limbs
Patient has had a lower limb amputation, malformation, alterations in leg muscles, or a history of musculoskeletal disease
Patient has used oral contraceptive pills or hormone replacement therapy within 3 months of screening
Patient has a history of stroke or seizures
Patient has a history of cancer, except that which was treated at least 10 years prior to screening and shows no evidence of recurrence
Clareo Health | A Study to Evaluate Methodologies for Measuring Swelling of the Leg and Ankle (MK-0000-106)(COMPLETED)
